Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Catherine Sanders

Catherine Sanders

Senior Director, Scientific Liaisons, Adaptive Biotechnologies Corp.

Catherine Sanders has more than 10 years of experience in the field of immunosequencing. She is currently Senior Director, Scientific Liaisons at Adaptive Biotechnologies responsible for establishing partnerships with pharmaceutical companies and collaborations with key opinion leaders in oncology, hematology, transplantation, infectious disease and autoimmunity.  Dr. Sanders received a Ph.D. in immunopathology and a M.S. in pathology from the University of Mississippi Medical Center in Jackson where she focused on TLR, chemokine receptor, and cytokine expression in HIV-infected T lymphocyte subsets. She also holds a BS degree in Medical Technology from Mississippi State University and received her board certification (ASCP) from Vanderbilt University Medical Center.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd